Botrista, Inc. is thrilled to announce that we have successfully raised $120,000,000 in funding. As a company dedicated to helping restaurants increase their profitability by simplifying the process of offering trending beverages, this significant investment will allow us to further expand our innovative solutions. With over 2,000 recipes spanning 15 different beverage categories, Botrista provides establishments with a comprehensive craft beverage platform that ensures quick, convenient, and high-quality drinks for their customers. This funding will enable us to enhance our technology, develop new products, and continue supporting our partners in staying ahead of consumer trends. We are excited to continue empowering restaurants to elevate their drink offerings, drive revenue growth, and enhance overall operational efficiency, ultimately fostering stronger customer loyalty and satisfaction.
Beverage Botrista Secures $120 Million in Series C Funding to Revolutionize Restaurant Drink Menus
Recently funded 路 $120.0M Series cBeverage Industry
Get the full Botrista, Inc. company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series c rounds
Companies that recently closed a Series c round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  SOLIVIS | Series c | $16.0M | 1d ago |
| 2 |  SKAN Switzerland | Series c | $63.0M | 1d ago |
| 3 |
